{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:47:11Z","timestamp":1767854831036,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jhep.2020.11.046","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T21:37:18Z","timestamp":1610055438000},"page":"505-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-2 leaves its mark in cirrhosis"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1049-1176","authenticated-orcid":false,"given":"Alice R.","family":"Burton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-9462","authenticated-orcid":false,"given":"Laura J.","family":"Pallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.11.046_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.11.046_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.11.046_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.046_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jhep.2020.10.012","article-title":"IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis","volume":"74","author":"Basho","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.11.046_bib5","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.immuni.2013.08.031","article-title":"Human circulating PD-1+CXCR3\u2212CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses","volume":"39","author":"Locci","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2020.11.046_bib6","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1172\/JCI125628","article-title":"T\u00a0follicular helper cells in human efferent lymph retain lymphoid characteristics","volume":"129","author":"Vella","year":"2019","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.11.046_bib7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.immuni.2012.02.012","article-title":"Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation","volume":"36","author":"Ballesteros-Tato","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2020.11.046_bib8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.3229","article-title":"The transcription factor TCF-1 initiates the differentiation of TFH cells during acute viral infection","volume":"16","author":"Xu","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhep.2020.11.046_bib9","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.celrep.2015.08.049","article-title":"TCF1 is required for the T follicular helper cell response to viral infection","volume":"12","author":"Wu","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2020.11.046_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.immuni.2015.06.013","article-title":"Salmonella infection drives promiscuous B cell activation followed by extrafollicular affinity maturation","volume":"43","author":"Di Niro","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2020.11.046_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.jhep.2020.11.046_bib12","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2020.11.046_bib13","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.4049\/jimmunol.0902580","article-title":"Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells","volume":"184","author":"Schurich","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2020.11.046_bib14","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming","volume":"574","author":"B\u00e9n\u00e9chet","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2020.11.046_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-230X-12-38","article-title":"Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes","volume":"12","author":"Seidler","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhep.2020.11.046_bib16","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jhep.2020.11.046_bib17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/hep.1840100606","article-title":"Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease","volume":"10","author":"M\u00fcller","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.11.046_bib18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41590-020-0744-z","article-title":"Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes","volume":"21","author":"Edner","year":"2020","journal-title":"Nat Immunol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820338332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:41:28Z","timestamp":1759174888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820338332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0168827820338332"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.046","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-2 leaves its mark in cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.10.012","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}